SYNTHON LICENSING LTD has a total of 11 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Slovenia, EPO (European Patent Office) and Czechia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are CHANTEST INC, TRIAD THERAPEUTICS INC and VITATEQ BIOTECHNOLOGY GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Slovenia | 7 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Czechia | 1 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Unspecified technologies | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Lemmens Jacobus Maria | 9 |
#2 | Benneker Franciscus Bernardus | 7 |
#3 | Peters Theodorus Hendricus Ant | 7 |
#4 | Picha Frantisek | 3 |
#5 | Keltjens Rolf | 2 |
#6 | Bakker Petrus Franciscus Anton | 1 |
#7 | Slanina Pavel | 1 |
#8 | Dalen Frans Van | 1 |
#9 | Ettema Gerrit J B | 1 |
#10 | Benneker | 1 |
Publication | Filing date | Title |
---|---|---|
CZ2002432A3 | Free amlodipine base | |
SI21121A | Amlodipine free base | |
SI21068A2 | Amlodipine maleate or its acid addition salt | |
SI21064A2 | Amide derivative of amlodipine | |
SI21065A2 | Aspartate derivative of amlodipine | |
SI21062A2 | Pharmaceutical compositions comprising amlodipine maleate | |
SI21066A2 | Amlodipine fumarate | |
SI21067A2 | Amlodipine hemimaleate | |
EP1309558A1 | Aspartate derivative of amlodipine as calcium channel antagonist | |
WO02054062A2 | Reference standards and processes for determining the purity or stability of amlodipine maleate |